Ginkgo Bioworks Holdings, Inc. (DNA)
8.50
-1.11
(-11.55%)
USD |
NYSE |
Nov 16, 16:00
8.56
+0.06
(+0.71%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Enterprise Value : 700.96M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 700.96M |
| November 12, 2026 | 739.09M |
| November 11, 2026 | 740.32M |
| November 10, 2026 | 848.55M |
| November 09, 2026 | 870.69M |
| November 06, 2026 | 804.28M |
| November 05, 2026 | 722.49M |
| November 04, 2026 | 826.42M |
| November 03, 2026 | 771.68M |
| November 02, 2026 | 715.72M |
| October 30, 2026 | 799.36M |
| October 29, 2026 | 893.45M |
| October 28, 2026 | 929.12M |
| October 27, 2026 | 803.05M |
| October 26, 2026 | 726.17M |
| October 23, 2026 | 724.33M |
| October 22, 2026 | 707.11M |
| October 21, 2026 | 725.56M |
| October 20, 2026 | 716.34M |
| October 19, 2026 | 729.25M |
| October 16, 2026 | 741.55M |
| October 15, 2026 | 833.18M |
| October 14, 2026 | 819.04M |
| October 13, 2026 | 833.18M |
| October 12, 2026 | 835.02M |
| Date | Value |
|---|---|
| October 09, 2026 | 909.44M |
| October 08, 2026 | 807.35M |
| October 07, 2026 | 815.35M |
| October 06, 2026 | 873.15M |
| October 05, 2026 | 1.031B |
| October 02, 2026 | 869.46M |
| October 01, 2026 | 878.69M |
| September 30, 2026 | 898.98M |
| September 29, 2026 | 825.14M |
| September 28, 2026 | 734.07M |
| September 25, 2026 | 746.22M |
| September 24, 2026 | 721.32M |
| September 23, 2026 | 619.94M |
| September 22, 2026 | 667.90M |
| September 21, 2026 | 583.51M |
| September 18, 2026 | 577.44M |
| September 17, 2026 | 575.01M |
| September 16, 2026 | 527.66M |
| September 15, 2026 | 523.41M |
| September 14, 2026 | 524.62M |
| September 11, 2026 | 508.83M |
| September 10, 2026 | 510.66M |
| September 09, 2026 | 511.26M |
| September 08, 2026 | 520.37M |
| September 04, 2026 | 520.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sotera Health Co. | 6.607B |
| CareDx, Inc. | 3.864B |
| Exagen, Inc. | 105.65M |
| Quest Diagnostics, Inc. | 34.44B |
| Labcorp Holdings, Inc. | 36.61B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.98M |
| Revenue (Quarterly) | 27.71M |
| Total Expenses (Quarterly) | 68.70M |
| EPS Diluted (Quarterly) | -0.6407 |
| Gross Profit Margin (Quarterly) | 50.04% |
| Profit Margin (Quarterly) | -147.9% |
| Earnings Yield | -54.47% |
| Normalized Earnings Yield | -53.68 |